Senior Leadership Team
QPS’ Senior Leadership Team (SLT) is collectively responsible for the global success of QPS. With representation from each of the global business functions and each of the global business sites, their primary responsibilities include exercising independent and objective judgement, as well as providing constructive challenges to local management teams to ensure the highest possible performance.
In addition, this team is responsible for setting strategy, developing policy, and monitoring progress towards meeting our annual goals and objectives. Our CEO, Dr. Ben Chien, leads the SLT, acts as the primary liaison to the Board of Directors, and has accountability for the annual performance of the global business. Dr. Chien also leads the SLT team through regular business performance reviews and challenges the team’s strategic thinking to improve results.

Ben Chien, Ph.D.

Ben Hsu, Ph.D. MBA

Brendon Bourg

Camille Picq, MBA
Head of Lab Services Business Development, Europe

Charlene Chen

ChauHwei Fu, Ph.D.

Dawn Moore
Head of Lab Services Business Development, US

Edwin van Vulpen

Gabrielle Pastore

John Kolman, Ph.D.

John Musante, MBA

Jose L. Marcos, CCRC, MT

Judy Morris

Kevin Vernarec

Kimberley Buytaert-Hoefen, Ph.D.

Kumar Ramu, Ph.D.

Manuela Prokesch, Ph.D.

Pedro Gonzalez

Robert Wronski, Ph.D.

Sarah Cross, Ph.D.

Vincent Yen, MBA

Wendy Finan

Wim Tamminga, Ph.D.

Zamas Lam, Ph.D.
We Help You Accelerate Pharmaceutical Breakthroughs
Business Development Team
QPS’ Business Development Team is collectively responsible for building strong relationships with existing and potential customers and generating business opportunities for QPS.
Through these relationships, the team shares comprehensive information about the global capabilities of QPS across Bioanalysis, Clinical Research Services, Dermal and Transdermal Research, DMPK, Neuropharmacology, Translational Medicine, Toxicology, as well as Early and Late Phase Clinical Trials. With team alignment across each of the global business functions and each of the global business sites, their primary responsibilities include understanding the specific needs of each individual customer and providing custom-built research service proposals to meet their very specific requirements.
Business development responsibilities are divided across 2 teams, both led by industry veterans, Zamas Lam, Ph.D., Sr. VP, Global Head, Bioanalytical and Global Head, Preclinical Development, and John Musante, Sr. VP, Global Head of Clinical Business Development. Please feel free to contact the QPS Business Development Team by email at [email protected], or look for us at an upcoming Conference. We look forward to the opportunity to custom-build your next clinical research solution.
Preclinical Business Development

Camille Picq, MBA
Head of Lab Services Business Development, Europe

Dawn Moore
Head of Lab Services Business Development, US

John Katiforis

Joy Concepcion

Mark Warren
Speak with us about your Global Preclinical Drug Development projects.
Early & Late Phase Clinical Business Development

John Musante, MBA

Edwin van Vulpen

Andrew Nehls, MS

Benjamin Abrams

Darlene Colon, MBA

Jim Cunningham

Jonathan Quinn

Mark McDonald

Maria Lundius

Robert Cathell
Let’s discuss your next Phase I – IV global clinical trial.
Global Business Development

Alex Chang

Andrew Lin

Bhavya Latha Thirunagari

Chen Huang

Doris Chi

Ewald Auer, MSc.

Joelle Kasbo

Matisse Liu

Nick Vrentzos M.Sc.

Roland Rabl

Stefanie Krassnig, Ph.D.

Tracy Tsai

Vera Niederkofler, Ph.D.

V.V.S Shiva Prasad, Ph.D.
Get in touch to plan a new global drug development study
Primary Investigator Team
QPS’ Primary Investigator Team is composed of dedicated physicians, supported by an extensive network of supplementary specialist physicians, who ensure consistent high-level study oversight from the early study planning stages through to study completion. Every QPS clinical trial site, across the USA, Europe, Taiwan and India, has a team of dedicated physicians to ensure that each clinical trial is run seamlessly. This highly experienced team maintains regular communication with the sponsor partners throughout the clinical trial process. We appreciate that working closely with the sponsor will yield the most efficient and successful trial.
The QPS Primary Investigator Team’s core responsibilities span the entire range of clinical trial activities, from early stage proposal development, to study design and ultimately, healthy volunteer and/or patient care.